APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 148 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 3.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $879,000 | -20.3% | 17,303 | -0.8% | 0.12% | -4.8% |
Q2 2021 | $1,103,000 | +208.1% | 17,447 | +109.0% | 0.12% | +110.2% |
Q1 2021 | $358,000 | +0.8% | 8,347 | +34.3% | 0.06% | +1.7% |
Q4 2020 | $355,000 | -24.0% | 6,215 | -59.9% | 0.06% | -25.6% |
Q3 2020 | $467,000 | +45.9% | 15,481 | +48.0% | 0.08% | +110.8% |
Q4 2019 | $320,000 | – | 10,461 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |